Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors

Clinical trial NCT06040541 · RECRUITING

Trial details

NCT number: NCT06040541
Sponsor: Revolution Medicines, Inc.
Status: RECRUITING
Phase: Phase 1
Study type: INTERVENTIONAL

Non-small Cell Lung Cancer (NSCLC)Colorectal Cancer (CRC)Pancreatic Ductal Adenocarcinoma (PDAC)Advanced Solid Tumors

Start date: 2023-09-07
Primary completion: 2026-12-31
Enrollment: 604

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.